Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

NCT01267643 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Study drug not available at this time

Conditions

Aplastic Anemia

Interventions

DRUG: Alefacept

Sponsor

The Cleveland Clinic

Collaborators

[object Object]